-
Pivotal announces participation in two clinical trials with a novel investigational immunotherapy drug to treat melanoma and lung cancer
-
Impressions from the visit to Wageningen, the specter of famine, CRISPR Cas9 to the rescue!
-
Reach out to potential partners and customers in the Danish-Swedish life science cluster, Medicon Valley
-
Central European Healthcare Expo (20-21.05.2020 Global Expo Warsaw)
The world of healthcare ...
All articles
2018-07-04
to
2019-07-11
Pivotal announces participation in two clinical trials with a novel investigational immunotherapy drug to treat melanoma and lung cancer
Pivotal, a specialist CRO, has been awarded two clinical trials for a novel investigational immunotherapy drug and patients' enrolment has now started. Pivotal will use its deep knowledge of oncology drug development to address a critical need for the expansion of immunotherapy programmes for Metasta... Read more
Tags clinical trials , pivotal , immunotherapy , Metastatic Melanoma , Non-Small Cell Lung Cancer
PIVOTAL and APRO partner to develop three Investigator Sponsored Trials in Genitourinary tumours
PIVOTAL and APRO have today announced a close collaboration in three different oncology clinical trials to test new treatment strategies delivered in an innovative way. The three trials have been recently approved by the Competent Authorities and the corresponding Ethics Committees and have already ... Read more
Tags clinical trials , oncology , PIVOTAL , APRO
2015-10-19
to
2018-10-16
Pharnext Announces Positive Topline Results from Pivotal Phase 3 Trial of PXT3003 for Treatment of Charcot-Marie-Tooth Type 1A Disease
Pharnext SA, a biopharmaceutical company pioneering a new approach to the development of innovative drug combinations based on big data genomics and artificial intelligence, today announced positive topline results from its pivotal Phase 3 clinical trial (PLEO-CMT) evaluating two doses of PXT3003 com... Read more
Tags clinical trials , Pharnext SA
Vaccine against AIDS in Phase I clinical trials
A vaccine based on HIV gp120 protein is a unique product for 15 years protection against infection. Unique, because it has been introduced by the team of Prof. Robert Gallo – a pioneer in the field of AIDS research and previous critic of disease-related vaccination.... Read more
Tags clinical trials , HIV , vaccine , AIDS , gp120
2015-08-12
Mutations in a cell line stops stem-cell trial to cure blindness
Induced pluripotent stem cells (iPSC) turned into specialized retinal cells were meant to cure the damage caused by age-related macular degeneration leading to blindness. The trial was halted due to mutations identified in cells of a second patient.... Read more
Tags clinical trials , stem cells , mutations , macular degeneration , blindness , iPSC
2013-03-13
to
2015-03-12
Potential of clinical trials in CEE region
Clinical trials are one of the indispensable steps of drug development. They are especially crucial for the assessment of effectiveness and safety of a novel medication. The whole pharmaceutical industry, which is growing rapidly all over the world, is trying to find new regions characterized by attr... Read more
Tags pharmaceutical , clinical trials , drug , CEE , company
Can the pepsin of pork treat HIV infection? – Clinical trials of innovative anti-HIV medicines in Bulgaria
On 23rd February Immunotech Laboratory announced $2M funding approval from its associate Bulgarian Immunotech Partnership Company (Immunotech BG) for clinical trials of the firm’s patented HIV-AIDS medicine. ... Read more
Tags medicine , pharmaceutical , clinical trials , bulgaria
2015-02-17
Pierre Fabre initiates Phase IIa trials for a new drug for Schizophrenia
A French multinational company Pierre Fabre Pharmaceuticals has announced a start of Phase IIa clinical trials for a new selective antagonist of dopamine D3 receptor called F17464 in patients suffering from schizophrenia. The major aim is to determine the effectiveness and assess safety of the drug d... Read more
Tags clinical trials , drug , Pierre Fabre , schizophrenia , F17464
2014-12-31
Gene therapy in 2014
The idea of gene therapy as a real therapeutic option began over 20 years ago. Since that time, there have been numerous moments of hope and disappointment that repeatedly changed the general opinion about this novel way of treatment. Today, together with advancements in human genomics, gene therapy ... Read more
Tags clinical trials , gene therapy , central Europe
2014-11-13
Clinical Trial Data more transparent
After lingering debates and discussions with stakeholders, the European Medicines Agency has finished a policy on the publication of clinical data regarding medical products for human use. The system that will allow future investigation of clinical trial information is not free from controversies.... Read more
Tags EMA , clinical trials , healthcare , data , policy
2014-04-11
Expert from Teva Pharmaceuticals about advantages of conducting clinical trials in CEE
There are plenty of Contract Research Organizations operating in Central and Eastern Europe (CEE) region. Pharmaceutical giants from all around the world are conducting clinical trails connected to development of their novel pharmaceuticals with their assistance, often preferring them over domestic c... Read more
Tags clinical trials , bioforum 2014 , Teva , Teva Pharmaceuticals , Yatif Stark
2014-02-05
The CEE region rising importance in bio-similar and bio-equivalent studies - KCR experts statements
The region of Central & Eastern Europe (CEE) has been growing dynamically as a life science market since mid-1990s. With high productivity and quality standards, the CEE market attracts more and more companies looking for reliable partners. KCR will lead a panel on clinical research in CEE during the... Read more
Tags medicine , clinical trials , CRO , drug development
2013-12-24
Political agreement on the draft EU Clinical Trials Regulation could enhance regulatory framework for clinical trials, but is not ambitious enough.
EuropaBio welcomes the political agreement on the draft Clinical Trials Regulation by the EU Committee of Permanent Representatives (COREPER) today, thus paving the way for the adoption of the Regulation by the co-legislators, the European Parliament and the Council, in 2014. The Clinical Trials Reg... Read more
Tags clinical trials , EuropaBio , European Parliament
Sandoz begins Phase III clinical trial for biosimilar adalimumab
Sandoz, the global leader in biosimilars, announced it has initiated a Phase III clinical trial with its biosimilar version of adalimumab (AbbVie’s HUMIRA®) – the leading treatment of several autoimmune conditions including rheumatoid arthritis, psoriasis, and Crohn’s disease. ... Read more
Tags biosimilars , clinical trials , Sandoz , adalimumab
2013-11-28
Transylvanian artificial blood made from sea worms
Transylvanian scientists are on the verge of inventing the artificial blood. In the Cluj-Napoca, the second most populous city in Romania the six-year experiment on mice was finished with no harmful side effects found. It was not only accepted by their bodies, but also did not caused any inflammation... Read more
Tags romania , clinical trials , blood , artificial blood , blood substitutes , preclinical
2013-04-05